These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7872965)

  • 1. MHC class I and autoimmune diabetes.
    Faustman DL
    Biomed Pharmacother; 1993; 47(1):3-10. PubMed ID: 7872965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linkage of faulty major histocompatibility complex class I to autoimmune diabetes.
    Faustman D; Li XP; Lin HY; Fu YE; Eisenbarth G; Avruch J; Guo J
    Science; 1991 Dec; 254(5039):1756-61. PubMed ID: 1763324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MHC class I-mediated antigen presentation and induction of CD8+ cytotoxic T-cell responses in autoimmune diabetes-prone NOD mice.
    Serreze DV; Gallichan WS; Snider DP; Croitoru K; Rosenthal KL; Leiter EH; Christianson GJ; Dudley ME; Roopenian DC
    Diabetes; 1996 Jul; 45(7):902-8. PubMed ID: 8666141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new look at MHC and autoimmune disease.
    Ridgway WM; Fassò M; Fathman CG
    Science; 1999 Apr; 284(5415):749, 751. PubMed ID: 10336398
    [No Abstract]   [Full Text] [Related]  

  • 5. Abnormal class I assembly and peptide presentation in the nonobese diabetic mouse.
    Li F; Guo J; Fu Y; Yan G; Faustman D
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11128-32. PubMed ID: 7972022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of self-peptide major histocompatibility complex class I reactivity in NOD and beta 2-microglobulin-negative mice.
    Huang R; Guo J; Li X; Faustman DL
    Diabetes; 1995 Sep; 44(9):1114-20. PubMed ID: 7657037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The murine autoimmune diabetes model: NOD and related strains.
    Kikutani H; Makino S
    Adv Immunol; 1992; 51():285-322. PubMed ID: 1323922
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of insulin-dependent diabetes mellitus in nonobese diabetic mice by immunogenic but not by tolerated peptides.
    Vaysburd M; Lock C; McDevitt H
    J Exp Med; 1995 Sep; 182(3):897-902. PubMed ID: 7650494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of MHC with autoimmune diseases: understanding the pathogenesis of autoimmune diabetes.
    Ridgway WM; Fathman CG
    Clin Immunol Immunopathol; 1998 Jan; 86(1):3-10. PubMed ID: 9434791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective major histocompatibility complex class I expression on lymphoid cells in autoimmunity.
    Fu Y; Nathan DM; Li F; Li X; Faustman DL
    J Clin Invest; 1993 May; 91(5):2301-7. PubMed ID: 8486790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes.
    Wicker LS; Appel MC; Dotta F; Pressey A; Miller BJ; DeLarato NH; Fischer PA; Boltz RC; Peterson LB
    J Exp Med; 1992 Jul; 176(1):67-77. PubMed ID: 1613467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NOD mice and autoimmunity.
    Aoki CA; Borchers AT; Ridgway WM; Keen CL; Ansari AA; Gershwin ME
    Autoimmun Rev; 2005 Jul; 4(6):373-9. PubMed ID: 16081028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tap-1 and Tap-2 gene therapy selectively restores conformationally dependent HLA Class I expression in type I diabetic cells.
    Wang F; Li X; Annis B; Faustman DL
    Hum Gene Ther; 1995 Aug; 6(8):1005-17. PubMed ID: 7578413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
    Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
    J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in diabetes incidence in an I-Ag7 transgenic nonobese diabetic mouse line.
    Wherrett DK; Singer SM; McDevitt HO
    Diabetes; 1997 Dec; 46(12):1970-4. PubMed ID: 9392482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmunity--towards the year 2001.
    Yeatman N; Sachs J; Bottazzo GF
    Immunol Today; 1992 Jul; 13(7):239-40. PubMed ID: 1356343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity.
    Schmidt D; Verdaguer J; Averill N; Santamaria P
    J Exp Med; 1997 Oct; 186(7):1059-75. PubMed ID: 9314555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice.
    Serreze DV; Holl TM; Marron MP; Graser RT; Johnson EA; Choisy-Rossi C; Slattery RM; Lieberman SM; DiLorenzo TP
    J Immunol; 2004 Jan; 172(2):871-9. PubMed ID: 14707058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune tolerance and type 1 (insulin-dependent) diabetes mellitus.
    Nossal GJ; Herold KC; Goodnow CC
    Diabetologia; 1992 Dec; 35 Suppl 2():S49-59. PubMed ID: 1478378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of robust diabetes resistance and prevention of recurrent type 1 diabetes following islet transplantation by gene therapy.
    Tian C; Ansari MJ; Paez-Cortez J; Bagley J; Godwin J; Donnarumma M; Sayegh MH; Iacomini J
    J Immunol; 2007 Nov; 179(10):6762-9. PubMed ID: 17982066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.